IMMUNIC, INC. - 8-K Filing
On June 29, 2026, Immunic, Inc. held its annual stockholder meeting where shareholders approved an amendment to the company's 2019 Omnibus Equity Incentive Plan, increasing the number of shares available for issuance by 6 million to a total of 8,644,887 shares. The vote was approved with 4,391,782 votes in favor and 1,361,843 against. Additionally, three Class III directors—Michael Bonney, Thorvald Nagel, and Richard Rudick—were elected to serve until the 2029 annual meeting. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits)
Tickers: $IMUX